Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
60,791,422
-
Shares change
-
+1,192,784
-
Total reported value, excl. options
-
$9,189,438,728
-
Value change
-
+$198,420,492
-
Put/Call ratio
-
99%
-
Number of buys
-
110
-
Number of sells
-
-81
-
Price
-
$151.17
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2024
240 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2024.
Ascendis Pharma A/S - ADR (ASND) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60,791,422 shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10,108,400 shares), Artisan Partners Limited Partnership (5,671,934 shares), FMR LLC (4,938,461 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (4,075,214 shares), Avoro Capital Advisors LLC (3,966,666 shares), JANUS HENDERSON GROUP PLC (3,767,203 shares), WELLINGTON MANAGEMENT GROUP LLP (2,745,872 shares), T. Rowe Price Investment Management, Inc. (2,568,903 shares), Capital International Investors (2,191,312 shares), and FRANKLIN RESOURCES INC (1,981,869 shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.